Difference between revisions of "Team:Linkoping Sweden/Demonstrate"

Line 61: Line 61:
 
</h3>
 
</h3>
 
<img src="https://static.igem.org/mediawiki/parts/6/65/T--Linkoping_Sweden--plasmid.png"/>
 
<img src="https://static.igem.org/mediawiki/parts/6/65/T--Linkoping_Sweden--plasmid.png"/>
 +
<h4>
 +
Figure x. Plasmids used in our experiments. pSub. can be either of mNG-Aß1-42, EGFP-Aß1-42, a-synuclein-EGFP and Tau0N4R-EGFP. As seen in the next figure, four combinations were introduced into E.coli (BL21). Substrate, substrate and GroES, substrate and GroES and GroE, substrate and GroE.
 
<h3>  
 
<h3>  
 
Overview of our experimental design to archive the results shown below
 
Overview of our experimental design to archive the results shown below
Line 66: Line 68:
 
<img src="https://static.igem.org/mediawiki/parts/9/92/T--Linkoping_Sweden--expdesign.png"/>
 
<img src="https://static.igem.org/mediawiki/parts/9/92/T--Linkoping_Sweden--expdesign.png"/>
 
<h4>Figure x. A simple explaination on how we archived our experimental results. The plasmids shown is the same as before, where A can be either of mNG-Aß1-42, EGFP-Aß1-42, a-synuclein-EGFP and Tau0N4R-EGFP, B is always pGroE7 and C is pSB4A5-GroES. The concentrations used for inducing the chaperone plasmids was 0.25 mg/ml L-arabinose, 200 ng/ml tetracycline. For the substrate plasmids we used 0.5 mM IPTG, and the substrate was induced 30 mins after the chaperone plasmids.
 
<h4>Figure x. A simple explaination on how we archived our experimental results. The plasmids shown is the same as before, where A can be either of mNG-Aß1-42, EGFP-Aß1-42, a-synuclein-EGFP and Tau0N4R-EGFP, B is always pGroE7 and C is pSB4A5-GroES. The concentrations used for inducing the chaperone plasmids was 0.25 mg/ml L-arabinose, 200 ng/ml tetracycline. For the substrate plasmids we used 0.5 mM IPTG, and the substrate was induced 30 mins after the chaperone plasmids.
 +
<h4/>
 
<h3>  
 
<h3>  
 
Results for the mNG-Aß1-42 substrate protein
 
Results for the mNG-Aß1-42 substrate protein

Revision as of 17:07, 14 October 2018

LiU iGEM

Demonstrate

All work done on BBa_K2671420

Plasmids used during the characterization of our biobrick

Figure x. Plasmids used in our experiments. pSub. can be either of mNG-Aß1-42, EGFP-Aß1-42, a-synuclein-EGFP and Tau0N4R-EGFP. As seen in the next figure, four combinations were introduced into E.coli (BL21). Substrate, substrate and GroES, substrate and GroES and GroE, substrate and GroE.

Overview of our experimental design to archive the results shown below

Figure x. A simple explaination on how we archived our experimental results. The plasmids shown is the same as before, where A can be either of mNG-Aß1-42, EGFP-Aß1-42, a-synuclein-EGFP and Tau0N4R-EGFP, B is always pGroE7 and C is pSB4A5-GroES. The concentrations used for inducing the chaperone plasmids was 0.25 mg/ml L-arabinose, 200 ng/ml tetracycline. For the substrate plasmids we used 0.5 mM IPTG, and the substrate was induced 30 mins after the chaperone plasmids.

Results for the mNG-Aß1-42 substrate protein

Results for the EGFP-Aß1-42 substrate protein

Results for the a-synuclein-EGFP substrate protein

Results for the Tau0N4R-EGFP substrate protein